Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 45% ± 14% | |
lung | 17 studies | 36% ± 12% | |
intestine | 11 studies | 34% ± 12% | |
kidney | 8 studies | 33% ± 8% | |
bone marrow | 6 studies | 28% ± 10% | |
lymph node | 6 studies | 43% ± 10% | |
pancreas | 5 studies | 40% ± 18% | |
placenta | 5 studies | 28% ± 9% | |
liver | 5 studies | 44% ± 19% | |
eye | 4 studies | 24% ± 8% | |
uterus | 4 studies | 45% ± 14% | |
breast | 4 studies | 37% ± 6% | |
brain | 4 studies | 24% ± 5% | |
adrenal gland | 3 studies | 31% ± 9% | |
thymus | 3 studies | 58% ± 27% | |
prostate | 3 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 2321.19 | 258 / 258 | 100% | 87.29 | 230 / 230 |
esophagus | 100% | 1631.86 | 1445 / 1445 | 100% | 81.43 | 183 / 183 |
intestine | 100% | 1815.36 | 966 / 966 | 100% | 137.09 | 527 / 527 |
kidney | 100% | 2013.97 | 89 / 89 | 100% | 76.90 | 901 / 901 |
liver | 100% | 1225.44 | 226 / 226 | 100% | 72.46 | 406 / 406 |
ovary | 100% | 2958.54 | 180 / 180 | 100% | 190.73 | 430 / 430 |
pancreas | 100% | 1639.85 | 328 / 328 | 100% | 90.02 | 178 / 178 |
prostate | 100% | 2204.03 | 245 / 245 | 100% | 97.57 | 502 / 502 |
skin | 100% | 2241.89 | 1809 / 1809 | 100% | 87.19 | 472 / 472 |
stomach | 100% | 1672.52 | 359 / 359 | 100% | 129.42 | 286 / 286 |
thymus | 100% | 1814.97 | 653 / 653 | 100% | 107.21 | 605 / 605 |
uterus | 100% | 1876.02 | 170 / 170 | 100% | 103.11 | 459 / 459 |
lung | 100% | 1738.73 | 578 / 578 | 100% | 86.58 | 1154 / 1155 |
bladder | 100% | 1929.76 | 21 / 21 | 100% | 113.85 | 503 / 504 |
brain | 100% | 935.51 | 2634 / 2642 | 100% | 70.75 | 705 / 705 |
breast | 100% | 2074.86 | 459 / 459 | 99% | 87.36 | 1111 / 1118 |
adipose | 100% | 2025.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 93.77 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 209.97 | 29 / 29 |
spleen | 100% | 2437.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 94.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 83.04 | 1 / 1 |
blood vessel | 100% | 1875.48 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1272.77 | 797 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1940.74 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1543.19 | 851 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0047497 | Biological process | mitochondrion transport along microtubule |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007098 | Biological process | centrosome cycle |
GO_0050821 | Biological process | protein stabilization |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0006915 | Biological process | apoptotic process |
GO_0005856 | Cellular component | cytoskeleton |
GO_1990062 | Cellular component | RPAP3/R2TP/prefoldin-like complex |
GO_0000922 | Cellular component | spindle pole |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0101031 | Cellular component | protein folding chaperone complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0048487 | Molecular function | beta-tubulin binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0008017 | Molecular function | microtubule binding |
GO_0005515 | Molecular function | protein binding |
Gene name | UXT |
Protein name | Protein UXT (Androgen receptor trapped clone 27 protein) (ART-27) (Ubiquitously expressed transcript protein) Ubiquitously expressed prefoldin like chaperone |
Synonyms | HSPC024 |
Description | FUNCTION: Involved in gene transcription regulation . Acts in concert with the corepressor URI1 to regulate androgen receptor AR-mediated transcription . Together with URI1, associates with chromatin to the NKX3-1 promoter region . Negatively regulates the transcriptional activity of the estrogen receptor ESR1 by inducing its translocation into the cytoplasm . May act as nuclear chaperone that facilitates the formation of the NF-kappa-B enhanceosome and thus positively regulates NF-kappa-B transcription activity . Potential component of mitochondrial-associated LRPPRC, a multidomain organizer that potentially integrates mitochondria and the microtubular cytoskeleton with chromosome remodeling . Increasing concentrations of UXT contributes to progressive aggregation of mitochondria and cell death potentially through its association with LRPPRC . Suppresses cell transformation and it might mediate this function by interaction and inhibition of the biological activity of cell proliferation and survival stimulatory factors like MECOM . .; FUNCTION: [Isoform 1]: Plays a role in protecting cells against TNF-alpha-induced apoptosis by preventing the recruitment of FADD and caspase 8 to the apoptotic complex I, composed of TRADD, TRAF2 and RIPK1/RIP. . |
Accessions | Q9UBK9 ENST00000485641.5 ENST00000333119.8 [Q9UBK9-1] S4R2Z4 ENST00000335890.3 [Q9UBK9-2] |